Clinical Trials
3 trialsNCT07614048 2026-05-29
Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS
Providence Health & Services
Temporarily not available
NCT05389514 2025-11-20
Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors
Providence Health & Services
Temporarily not available
NCT06090864 2025-10-20
ATLCAR.CD30.CCR4 for CD30+ HL ATLCAR.CD30.CCR4 Cells
UNC Lineberger Comprehensive Cancer Center
Phase 1/2 Recruiting